LYNX CAPITAL GROUP LTD /ADV’s scPharmaceuticals SCPH Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$113K	–	89
2025 Q3	$113K	Sell	20,000 -19,000	-49%	-$97.3K	0.05%	82
2025 Q2	$149K	Buy	+39,000	New	+$121K	0.07%	79

LYNX CAPITAL GROUP LTD /ADV's SCPH Position: Q4 2025 in Review

LYNX CAPITAL GROUP LTD /ADV sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 20,000 shares — an estimated $113K sold.

LYNX CAPITAL GROUP LTD /ADV first reported a position in SCPH in Q2 2025 and held it in 2 quarters. The position peaked at $149K in Q2 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

LYNX CAPITAL GROUP LTD /ADV reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
LYNX CAPITAL GROUP LTD /ADV sold 20,000 scPharmaceuticals shares in Q4 2025, an estimated $113K.
LYNX CAPITAL GROUP LTD /ADV first reported a position in scPharmaceuticals in Q2 2025 and held it in 2 quarters.
LYNX CAPITAL GROUP LTD /ADV's scPharmaceuticals position peaked at $149K in Q2 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2025.